We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
As pupils and students return to school following the Christmas break, UKHSA is reminding people that winter illnesses continue to circulate at high levels.
England joins a growing list of countries across the world to announce temporary measures as COVID cases rise in China ahead of borders re-opening next week.
First published during the 2022 to 2024 Sunak Conservative government
Moderna to invest in mRNA research and development (R&D) in the UK, and build a state-of-the-art vaccine manufacturing centre with the ability to produce up to 250 million vaccines a year.
This new vaccine, VidPrevtyn Beta, has been authorised after meeting the MHRA’s required safety, quality and effectiveness standards.
The UK Commission on Covid Commemoration held its fifth meeting.
The Comirnaty COVID vaccine has met the MHRA’s required safety, quality and effectiveness standards to be authorised for use in this age group
The UK Health Security Agency (UKHSA) has published findings of an investigation following errors at the private Immensa laboratory in Wolverhampton.
The UK Commission on Covid Commemoration held its fourth meeting.
Health and Social Care Secretary Steve Barclay will address the NHS workforce at the NHS Providers’ annual conference.
This adapted COVID-19 vaccine targets both the original virus and the Omicron BA.4 and BA.5 sub-variants.
A user experience evaluation conducted by the Home Test Service in collaboration with the Royal National Institute of Blind People, the Macular Society, the Thomas Pocklington Trust, Visionary and the Torch Trust.
A user experience evaluation conducted by the PCR Home Test Service in collaboration with the Royal National Institute of Blind People, the Macular Society, Visionary and the Thomas Pocklington Trust.
Describes the obstacles experienced by Hackney Council and its public health team in supporting testing, and the local responses implemented to overcome challenges.
People across the UK are being invited to have their say on how the nation should remember those who lost their lives during the Covid-19 pandemic.
COVID-19 and flu marketing campaign launches tomorrow encouraging eligible people to get their vaccines ahead of the winter.
The British Government donated PPE to Honduras to support Covid-19 pandemic response.
First published during the 2022 Truss Conservative government
The Commission met for the third time, on Tuesday 4 October 2022.
Community diagnostic centres across the country have now delivered over 2 million vital checks, helping to bust the COVID backlogs.
Government’s Vaccine Taskforce has granted £10.65 million in additional funding to support the launch of Darlington RNA vaccine innovation centre.
The Secretary of State for Health and Social Care's letter to a group of charities and patients on the decision not to procure Evusheld as a COVID-19 treatment.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).